Zepbound (tirzepatide) – Now Approved for…

Grunberger Diabetes & Endocrinology Medical News Articles Zepbound (tirzepatide) – Now Approved for…
0 Comments

Zepbound (tirzepatide) – Now Approved for…

The FDA on November 8, 2023 approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity. Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro used along with diet and exercise to help improve blood sugar (glucose) in adults with type 2 diabetes mellitus.

Approximately 70% of American adults have obesity or are overweight, and many of those overweight have a weight-related condition. Losing 5% to 10% of body weight through diet and exercise has been associated with a reduced risk of cardiovascular disease in adults with obesity or overweight.

Zepbound activates receptors of hormones secreted from the small intestine when we eat (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)) to reduce appetite and food intake. Zepbound is administered by injection under the skin once weekly, and the dosage is being increased over four to 20 weeks as tolerated to achieve the target dosages of 5 milligram (mg), 10 mg or 15 mg (the maximum dose) once weekly. 

The most common side (5% or more) effects reported with Zepbound are nausea, vomiting, diarrhea and constipation. The key to avoiding or minimizing these side effects is to stop eating when feeling full, eating slowly, and trying to minimize intake of fatty foods. Side effects are typically mild to moderate and tend to disappear within weeks or few months. Most people in the studies have tolerated it without serious side effects.

About Grunberger Diabetes Institute

At Grunberger Diabetes Institute (GDI), we have the knowledge and expertise to assist you on your journey. We have a certificate of recognition from the American Diabetes Association for our Diabetes Self-Management Education Program, and doctors to help you manage your overall health. What makes GDI different is that we are a small business that takes the time to look at your health holistically, and are a one-stop-shop for all your endocrine and weight management needs.

Grunberger Diabetes Institute (GDI) provides Diabetes and Endocrine management, as well as a weight management program. Your well-being is assessed on an individual level and the treatment includes a plan for the improvement of your overall health and quality of life. We specialize in all things related to diabetes, endocrine, and weight management. This includes but isn’t limited to: diabetic neuropathy, dyslipidemia, obesity, diabetic recipes, reproductive endocrinology, osteoporosis treatment, male hypogonadism, hypercalcemia, all issues and diseases involving the thyroid gland (including thyroid cancer), patients transitioning from pediatric endocrinology to adult endocrinology, type 1 and type 2 diabetes. Schedule with us today to find out why we’re voted the best Endocrinology practice.

Categories:

Related Posts

FreeStyle Libre 2 Plus is Now Available!
FreeStyle Libre 2 Plus is Now Available! Those among you who follow the field of
Mobi is finally here!
Mobi is finally here! It has been a while (at least since 2021) since Tandem
Upcoming Diabetes Event Near You!
Upcoming Diabetes Event Near You! Join us Saturday, June 1, 2024, from 8:00 a.m. to